The DOI matches its Crossref record; 93 of the 98 references it cites were found in a registry or an index.
Update Review about Metabolic Myopathies
Open accessAbstract
The aim of this review is to summarize and discuss recent findings and new insights in the etiology and phenotype of metabolic myopathies. The review relies on a systematic literature review of recent publications. Metabolic myopathies are a heterogeneous group of disorders characterized by mostly inherited defects of enzymatic pathways involved in muscle cell metabolism. Metabolic myopathies present with either permanent (fixed) or episodic abnormalities, such as weakness, wasting, exercise-intolerance, myalgia, or an increase of muscle breakdown products (creatine-kinase, myoglobin) during exercise. Though limb and respiratory muscles are most frequently affected, facial, extra-ocular, and axial muscles may be occasionally also involved. Age at onset and prognosis vary considerably. There are multiple disease mechanisms and the pathophysiology is complex. Genes most recently related to metabolic myopathy include PGM1, GYG1, RBCK1, VMA21, MTO1, KARS, and ISCA2. The number of metabolic myopathies is steadily increasing. There is limited evidence from the literature that could guide diagnosis and treatment of metabolic myopathies. Treatment is limited to mainly non-invasive or invasive symptomatic measures. In conclusion, the field of metabolic myopathies is evolving with the more widespread availability and application of next generation sequencing technologies worldwide. This will broaden the knowledge about pathophysiology and putative therapeutic strategies for this group of neuromuscular disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Accordingly, premature fatigue (i.e. a faster drop in force) related to decreased mitochondrial oxidative capacity has been shown to precede overt muscle weakness in mouse models with mitochondrial dysfunction, as well as in patients with mitochondrial myopathies (Finsterer, 2020; Tarnopolsky, 2016; Yamada et al., 2012).”
From Impaired aerobic capacity and premature fatigue preceding muscle weakness in the skeletal muscle Tfam-knockout mouse model (2021) · cites this paper as Finsterer, 2020
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These results extend those from previous studies showing severe muscle weakness in more advanced stages of the disease (Gineste et al., 2015; Wredenberg et al., 2002), and support those reported in patients related to a progression from early premature fatigue to disabling muscle weakness at rest (Finsterer, 2020; Tarnopolsky, 2016).”
From Impaired aerobic capacity and premature fatigue preceding muscle weakness in the skeletal muscle Tfam-knockout mouse model (2021) · cites this paper as Finsterer, 2020
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boisson, B., Laplantine, E., Prando, C., Giliani, S., Israelsson, E., Xu, Z., Abhyankar, A., Israël, L., Trevejo-Nunez, G., Bogunovic, D., et al. (2012) · Nature Immunology · doi:10.1038/ni.2457 · Cited by 474
Treatment recommendations in long‐chain fatty acid oxidation defects: consensus from a workshop
Spiekerkoetter, U., Lindner, M., Santer, R., Grotzke, M., Baumgartner, M. R., Boehles, H., Das, A., Haase, C., Hennermann, J. B., Karall, D., et al. (2009) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-009-1126-8 · Cited by 220
The emerging phenotype of late-onset Pompe disease: A systematic literature review
Chan, J., Desai, A. K., Kazi, Z. B., Corey, K., Austin, S., Hobson-Webb, L. D., Case, L. E., Jones, H. N., & Kishnani, P. S. (2017) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2016.12.004 · Cited by 188
Glycogen storage disease type III: diagnosis, genotype, management, clinical course and outcome
Sentner, C. P., Hoogeveen, I. J., Weinstein, D. A., Santer, R., Murphy, E., McKiernan, P. J., Steuerwald, U., Beauchamp, N. J., Taybert, J., Laforêt, P., et al. (2016) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-016-9932-2 · Cited by 178
Danon disease: a phenotypic expression of LAMP-2 deficiency
Endo, Y., Furuta, A., & Nishino, I. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1385-4 · Cited by 174
Polyglucosan body myopathy caused by defective ubiquitin ligase RBCK1
Nilsson, J., Schoser, B. G. H., Laforêt, P., Kalev, O., Lindberg, C., Romero, N. B., López, M. D., Akman, H. O., Wahbi, K., Iglseder, S., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23963 · Cited by 149
Arnold, G. L., Hove, J. V., Freedenberg, D. L., Strauss, A. W., Longo, N., Burton, B. K., Garganta, C. L., Ficicioglu, C. H., Cederbaum, S. D., Harding, C. O., et al. (2009) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2008.09.008 · Cited by 146
β‐enolase deficiency, a new metabolic myopathy of distal glycolysis
Comi, G. P., Fortunato, F., Lucchiari, S., Bordoni, A., Prelle, A. C., Jann, S., Keller, A., Ciscato, P., Galbiati, S., Chiveri, L. R., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1095 · Cited by 131
ISCA2 mutation causes infantile neurodegenerative mitochondrial disorder
Al‐Hassnan, Z. N., Aldosary, M. S., Alfadhel, M., Faqeih, E., Alsagob, M., Kenana, R., Almass, R., Al‐Harazi, O., Al‐Hindi, H., Malibari, O., et al. (2014) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2014-102592 · Cited by 108
Sharpe, A. J., & McKenzie, M. (2018) · Cells · doi:10.3390/cells7060046 · Cited by 108
Research works printed but not linked: 1
- Finsterer, 2011, Metabolische Myopathien, Jatr. Neurol. Psychiatr., 4, 26
Cited by
van den Bersselaar, L. R., Heytens, L., da Silva, H. C. A., Reimann, J., Tasca, G. A., Díaz‐Cambronero, Ó., Løkken, N., Hellblom, A., Hopkins, P. M., Rueffert, H., et al. (2022) · European Journal of Neurology · doi:10.1111/ene.15526 · Cited by 73
Rybalka, E., Park, H. J., Nalini, A., Baskar, D., Polavarapu, K., Durmuş, H., Xia, Y., Wan, L., Shieh, P. B., Moghadaszadeh, B., et al. (2024) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-024-03429-x · Cited by 14
Filamented Light (FLight) Bioprinting of Mini‐Muscles with Self‐Renewal Potential
Liu, H., Winkelbauer, M., Janiak, J., Weber, P., Kalkan, A. K., Kim, I., Chansoria, P., Bar‐Nur, O., & Zenobi‐Wong, M. (2025) · Advanced Materials · doi:10.1002/adma.202501147 · Cited by 18
Update on Exercise in Persons With Muscle Disease
Mamarabadi, M., Kudritzki, V., Li, Y., & Howard, I. M. (2025) · Muscle & Nerve · doi:10.1002/mus.28356 · Cited by 12
Ijaz, A., Abbas, S., Shabbir, M., Badshah, Y., Abid, F., Afsar, T., & Razak, S. (2025) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-025-03979-8 · Cited by 10
Metadata
- Authors
- Finsterer, J.
- Affiliations
- Krankenanstalt Rudolfstiftung der Stadt Wien (AT)
- Corresponding author
- Finsterer, Josef
- ORCID
- Finsterer, Josef
- Venue
- Life
- Publisher
- MDPI AG
- Published
- 2020-04-17
- Volume
- 10
- Issue
- 4
- Pages
- 43
- ISSN
- 2075-1729 (ISSN-L)
- PMC
- PMC7235760
- OpenAlex
- W3017154056
- Cited by
- 31
- References
- 98
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 4 · 2023: 5 · 2022: 6 · 2021: 3
- FWCI
- 0.44
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Life (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Keywords
- metabolic myopathies, hereditary muscle disease, muscle metabolism, exercise intolerance, creatine kinase, myoglobinuria, PGM1, RBCK1, MTO1, Kars, genetic diagnosis, next-generation sequencing, neuromuscular disorders, pathophysiology, treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Update Review about Metabolic Myopathies. https://app.cochat.ai/papers/10.3390/life10040043
- The paper
- Finsterer, J. (2020). Update Review about Metabolic Myopathies. Life. https://doi.org/10.3390/life10040043
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.